Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products... Show more
LNTH saw its Momentum Indicator move below the 0 level on August 06, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 75 similar instances where the indicator turned negative. In of the 75 cases, the stock moved further down in the following days. The odds of a decline are at .
The Moving Average Convergence Divergence Histogram (MACD) for LNTH turned negative on August 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
LNTH moved below its 50-day moving average on July 16, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for LNTH crossed bearishly below the 50-day moving average on July 21, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LNTH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for LNTH entered a downward trend on August 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where LNTH advanced for three days, in of 342 cases, the price rose further within the following month. The odds of a continued upward trend are .
LNTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.158) is normal, around the industry mean (16.611). P/E Ratio (14.410) is within average values for comparable stocks, (72.068). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.758). LNTH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (2.562) is also within normal values, averaging (40.357).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. LNTH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
a manufacturer of medical imaging products
Industry PharmaceuticalsGeneric
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSAKX | 20.20 | 0.08 | +0.40% |
Goldman Sachs International Eq Inc A | |||
JAMRX | 96.47 | -0.25 | -0.26% |
Janus Henderson Research T | |||
MARFX | 23.75 | -0.08 | -0.34% |
BlackRock Mid-Cap Value Institutional | |||
ISFIX | 17.58 | -0.07 | -0.40% |
VY® Columbia Contrarian Core I | |||
ODMCX | 10.88 | -0.08 | -0.73% |
JPMorgan SMID Cap Equity C |
A.I.dvisor indicates that over the last year, LNTH has been loosely correlated with EOLS. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if LNTH jumps, then EOLS could also see price increases.
Ticker / NAME | Correlation To LNTH | 1D Price Change % | ||
---|---|---|---|---|
LNTH | 100% | -0.53% | ||
EOLS - LNTH | 33% Loosely correlated | +5.16% | ||
ACET - LNTH | 32% Poorly correlated | +0.80% | ||
SNDL - LNTH | 26% Poorly correlated | -4.27% | ||
LFCR - LNTH | 24% Poorly correlated | -0.67% | ||
ORGO - LNTH | 24% Poorly correlated | +0.64% | ||
More |
Ticker / NAME | Correlation To LNTH | 1D Price Change % |
---|---|---|
LNTH | 100% | -0.53% |
Pharmaceuticals: Generic industry (227 stocks) | 7% Poorly correlated | -1.82% |